![](/img/cover-not-exists.png)
Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL
Sanchez-Garcia, J, Serrano, J, Serrano-Lopez, J, Gomez-Garcia, P, Martinez, F, Garcia-Castellano, J M, Rojas, R, Martin, C, Rodriguez-Villa, A, Molina-Hurtado, J R, Alvarez, M A, Casaño, J, Torres-GomVolume:
48
Language:
english
Journal:
Bone Marrow Transplantation
DOI:
10.1038/bmt.2012.147
Date:
March, 2013
File:
PDF, 515 KB
english, 2013